Rhumbline Advisers Fulgent Genetics, Inc. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 68,210 shares of FLGT stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,210

Previous 67,573 0.94%

Holding current value

$1.5 Million

Previous $1.47 Million 8.73%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$19.09 - $22.57 $12,160 - $14,377	637 Added 0.94%	68,210 $1.34 Million
Q1 2024 May 09, 2024	BUY	$21.55 - $29.29 $22,131 - $30,080	1,027 Added 1.54%	67,573 $1.47 Million
Q4 2023 Feb 08, 2024	BUY	$23.64 - $30.27 $15,531 - $19,887	657 Added 1.0%	66,546 $1.92 Million
Q3 2023 Nov 09, 2023	BUY	$26.74 - $40.81 $21,846 - $33,341	817 Added 1.26%	65,889 $1.76 Million
Q2 2023 Aug 08, 2023	SELL	$28.52 - $40.7 $23,129 - $33,007	-811 Reduced 1.23%	65,072 $2.41 Million
Q1 2023 May 11, 2023	BUY	$29.39 - $36.27 $50,462 - $62,275	1,717 Added 2.68%	65,883 $2.06 Million
Q4 2022 Feb 14, 2023	BUY	$29.23 - $40.28 $54,747 - $75,444	1,873 Added 3.01%	64,166 $1.91 Million
Q3 2022 Nov 10, 2022	BUY	$37.92 - $63.74 $94,610 - $159,031	2,495 Added 4.17%	62,293 $2.38 Million
Q2 2022 Aug 11, 2022	BUY	$47.98 - $62.75 $222,003 - $290,344	4,627 Added 8.39%	59,798 $3.26 Million
Q1 2022 May 12, 2022	BUY	$49.85 - $96.11 $105,432 - $203,272	2,115 Added 3.99%	55,171 $3.44 Million
Q4 2021 Feb 10, 2022	BUY	$77.3 - $105.0 $22,648 - $30,765	293 Added 0.56%	53,056 $5.34 Million
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $343,129 - $508,117	-4,583 Reduced 7.99%	52,763 $4.75 Million
Q2 2021 Aug 05, 2021	BUY	$66.8 - $100.45 $887,638 - $1.33 Million	13,288 Added 30.16%	57,346 $5.29 Million
Q1 2021 May 06, 2021	BUY	$59.3 - $183.85 $531,683 - $1.65 Million	8,966 Added 25.55%	44,058 $4.26 Million
Q4 2020 Feb 10, 2021	BUY	$31.01 - $52.1 $250,715 - $421,228	8,085 Added 29.94%	35,092 $1.83 Million
Q3 2020 Nov 12, 2020	BUY	$15.89 - $50.51 $429,141 - $1.36 Million	27,007 New	27,007 $1.08 Million

Others Institutions Holding FLGT

# of Institutions

192

Shares Held

15.1M

Call Options Held

1.07M

Put Options Held

27.9K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $666M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Fulgent Genetics, Inc. Transaction History